Magdy Abdelhamid
Magdy Abdelhamid is an expert in Cardiology at Cairo University hospitals (Egypt). As of October 2026, ScienceLeadR ranks Magdy Abdelhamid in the top 1% of experts worldwide for Hypotension and Heart Failure. Magdy Abdelhamid has authored 122 publications, the most recent in 2026, and is an investigator in 17 clinical trials, 3 of them ongoing. SLR score: 931 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Biostatistics - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2014 - 2026
Number : 122
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 17
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Effect of Electroacupuncture on Central Obesity and Fatty Liver in Postmenopausal Women NCT07437001 — orlistat, acupuncture points, electroacupuncture, liver, diet, energy intake, obesity, therapeutics, obesity, abdominal, supine position, fatty liver, needles, gynecologists, women | N/A | Not yet recruiting | 2026 |
| Benson Relaxation Technique Effectiveness on Pain and Quality of Life Post Reconstructive Mammoplasty NCT07032883 — eye, exercise, quality of life, relaxation therapy, clindamycin, muscles, hospitalization, breast neoplasms, respiration, pain, ampicillin, ketorolac, neoplasms, foot, tablets, acetaminophen, mammaplasty, breast, cephalexin, cephalosporins, cefazolin, posture, therapeutics, nose, celecoxib | N/A | Not yet recruiting | 2025 |
| Role of Colchicine as Anti Inflammatory Therapy in HFpEF NCT06837623 — colchicine, heart failure, heart, heart failure, diastolic, tablets, therapeutics, prospective studies | Phase 3 | Active not recruiting | 2024 |
LeadR Networks
Main global connection map